Lawmakers ask HHS to probe the Medicaid drug rebate program
(By Ed Silverman for STAT) In the wake of the controversy over EpiPen pricing,1 a group of lawmakers is demanding
Read More
Legal Actions/Court Decisions
FDA panel votes to remove serious warning from Pfizer’s smoking cessation pill
(By Ed Silverman for STAT) Pfizer won a crucial battle in its quest to widen the market for its Chantix
Read MoreFDA weighs crackdown that could shut hundreds of stem cell clinics
(By Usha Lee McFarling for STAT) Scientists on Monday will urge the Food and Drug Administration to crack down on
Read MoreEpiPen maker under investigation for antitrust violations in New York
(By Ike Swetlitz for STAT) New York Attorney General Eric T. Schneiderman is investigating Mylan Pharmaceuticals for potential antitrust violations involving
Read MoreCalifornia court hangs out a welcome sign: Drug makers can be sued here
(By Ed Silverman for STAT) In a closely watched decision, the California Supreme Court ruled 4-3 Monday that hundreds of
Read MoreAnother Biosimilar Wins FDA Approval
U.S. Food and Drug Administration (FDA) approved Novartis’s Sandoz drug Erelzi (biosimilar copy of Amgen’s Enbrel) on Tuesday but it
Read MoreDoctors Sue Obama Administration for Forcing Them to Perform Gender Transition Procedures
(By Kelsey Harkness for The Daily Signal) Five states and a group of religiously-affiliated hospitals and physicians are suing the
Read MoreCMS Identifies Hospitals Paid Nearly $1.5B In 2015 Medicare Billing Settlement
(By Phil Galewitz for Kaiser Health News) A year after paying nearly $1.5 billion to more than a third of
Read MoreLies, damn lies, and CRISPR: the legal battle escalates
(By Sharon Begley for STAT) Beneath the technical and legal jargon in the latest documents filed in the battle over
Read MoreACLU threatens to sue Colorado over hepatitis C drug restrictions
(By Ed Silverman for STAT) In the latest dust-up over the high cost of hepatitis C drugs, the American Civil
Read More